Corporate Profile

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. Leveraging Nurix’s extensive expertise in E3 ligases together with proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates that can modulate proteins within the cell.

Show All
When was Nurix Therapeutics founded?
Nurix Therapeutics was founded in 2009.
Where is Nurix Therapeutics headquartered?
Our corporate headquarters and research laboratories are located in San Francisco, CA.
In what state and year is Nurix Therapeutics incorporated?
We were incorporated in August 2009 in the state of Delaware under the name Kura Therapeutics, changed our name to Nurix, Inc. in February 2012 and then to Nurix Therapeutics, Inc. in October 2018.
On which exchange is Nurix Therapeutics listed and what is the ticker?
Our common stock is listed on the Nasdaq Stock Market under the symbol NRIX.
When did Nurix Therapeutics go public?
Nurix Therapeutics started trading publicly on July 24, 2020.
Who is Nurix Therapeutics’ transfer agent and how do I contact them?
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC. 
How can I invest in Nurix Therapeutics?
You can purchase our common stock through a registered brokerage or stock purchase service provider of your choice.
Can I purchase Nurix Therapeutics stock directly from the company?
Unfortunately, you cannot purchase stock directly from Nurix Therapeutics.
Can I obtain a stock certificate for my shares of Nurix Therapeutics stock?
If your shares are held in street name, you should contact the broker from whom you purchased your shares or if you hold your shares in your name, please contact our transfer agent, American Stock Transfer & Trust Company, LLC.
If my address changes, whom should I notify?
If your shares are held in your name, you must contact our transfer agent, American Stock Transfer & Trust Company, LLC. If your shares are held in street name, you must contact your broker to update your address.
When does Nurix Therapeutics report financial results?
If a financial report date has been scheduled, the details will posted under Events page found within the “Investors” section of our website.
Who are Nurix Therapeutics’ independent auditors?
Our independent registered public accounting firm is PricewaterhouseCoopers LLP.
Does Nurix Therapeutics pay a cash dividend?
Nurix Therapeutics has never declared or paid cash dividends on its common stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any cash dividends on our common stock in the foreseeable future.
Can I listen to an investor webcast event?
All webcasts can be accessed on the Events page found within the “Investors” section of our website.
When and where is the Annual Stockholder’s Meeting? How can I attend?
The date, time and location of our Annual Meeting of Stockholders is announced in our annual proxy statement filed with the SEC and is available at SEC Filings page found within the “Investors” section of our website.
Where can I find Nurix Therapeutics’ SEC filings?
Our SEC filings are available on the Financial Information page under the Investor Relations section of our website.
How do I contact investor relations?
Please reach out to for any questions regarding investor relations.
How do I obtain the latest Nurix Therapeutics’ financial information?
Please visit the Financial Information pages of the Investor Relations section of our website.